[1] Nambirajan Govindarajan, Roberto Carlos Agis-Balboa, Jonas Walter, et al. Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression [J]. J Alzheimers Dis, 2011, 26(1): 187-197.[2] Frederick A Schroeder, Cong Lily Lin, Wim E Crusio, et al. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse[J]. Biol Psychiatry, 2007, 62(1): 55-64.[3] Brigitta B Gundersen, Julie A Blendy. Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety [J]. Neuropharmacology, 2009, 57(1): 67-74.[4] Lu P, Mamiya T, Lu LL, et al. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice [J]. Br J Pharmacol, 2009, 157(7): 1270-1277.[5] James R Davie. Inhibition of histone deacetylase activity by butyrate [J]. J Nutr, 2003, 133(Suppl 7): 2485S-2493S.[6] 宋玫香, 张岩, 王芳, 等. 丁酸钠通过维持乙酰化平衡改善PD鼠认知和情感障碍[J]. 中国药理学通报, 2012, 28(7): 421-426.[7] Wang Yong, Wang Xuan, Liu Li-min, et al. HDAC inhibitor trichostain A-inhibited survival of dopaminergic neuronal cells [J]. Neurosci Lett, 2009, 467(3): 212-216.[8] Lu P, Mamiya T, Lu LL, et al. Silibinin attenuates amyloid beta (25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice [J]. J Pharmacol Exp Ther, 2009, 331(1):319-326.[9] Zhou Bei, Wu Li-jun, Li Lin-hao, et al. Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1[J]. J Pharmacol Sci, 2006, 102(4): 387-395.[10] Angela Risch, Christoph Plass. Lung cancer epigenetics and genetics [J]. Int J Cancer, 2008, 123(1): 1-7.[11] Ivana V Yang, David A Schwartz. Epigenetic control of gene expression in the lung [J]. Am J Respir Crit Care Med, 2011, 183(10): 1295-1301.[12] Samiha Mateen, Komal Raina, Anil K Jain, et al. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells[J]. Epigenetics, 2012, 7(10): 1161-72. |